Trial Profile
Phase III trial of GLG-801 in patients with chronic lymphatic leukemia
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 04 Mar 2016
Price :
$35
*
At a glance
- Drugs GLG 801 (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- Sponsors GLG Pharma
- 04 Mar 2016 New trial record